These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Recent advances in the management of cholangiocarcinomas. Vauthey JN; Blumgart LH Semin Liver Dis; 1994 May; 14(2):109-14. PubMed ID: 8047893 [No Abstract] [Full Text] [Related]
11. Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report. Poggi G; Quaretti P; Minoia C; Palumbo I; Villani L; Amatu A; Teragni C; Scelsi M; Zappoli F; Bernardo G Anticancer Res; 2008; 28(5B):2987-90. PubMed ID: 19031944 [TBL] [Abstract][Full Text] [Related]
12. Extrahepatic cholangiocarcinoma: current surgical strategy. Boutros C; Somasundar P; Espat NJ Surg Oncol Clin N Am; 2009 Apr; 18(2):269-88, viii. PubMed ID: 19306812 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy of neoadjuvant chemoradiation therapy for clinical Stage II cholangiocarcinoma as a preoperative diagnosis]. Nakagawa K; Katayose Y; Unno M Gan To Kagaku Ryoho; 2012 Nov; 39(12):1945-7. PubMed ID: 23267938 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology. Baskin-Bey ES; Moreno Luna LE; Gores GJ J Hepatol; 2006 Oct; 45(4):476-9. PubMed ID: 16901574 [No Abstract] [Full Text] [Related]
15. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones". Hunt JP; Varnholt H Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649 [No Abstract] [Full Text] [Related]